Polatuzumab,Rituximab,Doxorubicin,Prednisone
roche,abbvie,biogen
['lymsm', 'dlbcl']
polachpr does not increase peripheral neuropathy in dlbcl #lymsm in comparison to rchop #asco22 
A hematologist @MoffittNews with interest in #lymsm. Tweets are not endorsements, and not medical advice.